SCHEMBL9308750

SCHEMBL9308750

CCc1cccc(NC(=O)CC(C)=O)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.66
HDAC3 O15379 2/20 0.64
HDAC4 P56524 2/20 0.64
HDAC1 Q13547 2/20 0.64
HDAC7 Q8WUI4 2/20 0.64
HDAC2 Q92769 2/20 0.64
HDAC10 Q969S8 2/20 0.64
HDAC11 Q96DB2 2/20 0.64
HDAC8 Q9BY41 2/20 0.64
HDAC6 Q9UBN7 2/20 0.64
HDAC9 Q9UKV0 2/20 0.64
HDAC5 Q9UQL6 2/20 0.64
HPGD P15428 1/20 0.64
MAPK1 P28482 1/20 0.64
SMN1; SMN2 Q16637 5/20 0.61
GAA P10253 4/20 0.57
KMT2A Q03164 3/20 0.57
LMNA P02545 2/20 0.57
HTT P42858 1/20 0.57
MEN1 O00255 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15828751 0.87 MEN1 (0.55) MAPTHDAC3HDAC4HDAC1HDAC7
SCHEMBL8324505 0.87 MAPT (0.66) MAPTHDAC3HDAC4HDAC1HDAC7
SCHEMBL9410518 0.86 MAPT (0.69) MAPTHDAC3HDAC4HDAC1HDAC7
SCHEMBL8752439 0.86 MEN1 (0.66) MAPTGAAKMT2ALMNAMEN1
SCHEMBL18530341 0.85 MAPT (0.64) MAPTHDAC3HDAC4HDAC1HDAC7
SCHEMBL7894861 0.85 MAPT (0.68) MAPTHDAC3HDAC4HDAC1HDAC7
SCHEMBL11679320 0.84 POLB (0.68) MAPTHDAC3HDAC4HDAC1HDAC7
SCHEMBL1817688 0.84 RAB9A (0.64) MAPTHDAC3HDAC4HDAC1HDAC7
SCHEMBL24538415 0.83 MAPT (0.75) MAPTHDAC3HDAC4HDAC1HDAC7
SCHEMBL4003071 0.83 MAPT (0.66) MAPTHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118185381-A Marek pen ink and preparation method thereof 深圳千岸科技股份有限公司 2024-06-14 CN disclosed
US-5371226-A Hypotensive agents MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1994-12-06 US disclosed
EP-0561252-A1 2-Oxoquinoline derivatives as angiotensin II antagonists MERCK PATENT GmbH (DE) 1993-09-22 EP disclosed